Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.64 |
| ▸ | CA2 | P00918 | 9/20 | 0.60 |
| ▸ | CA1 | P00915 | 8/20 | 0.60 |
| ▸ | CA9 | Q16790 | 8/20 | 0.60 |
| ▸ | CA4 | P22748 | 6/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8765541 | 0.94 | PTGS2 (0.62) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL8764356 | 0.88 | PTGS2 (0.53) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL8765473 | 0.86 | PTGS2 (0.76) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL8765113 | 0.86 | PTGS2 (0.62) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL6512916 | 0.82 | PTGS2 (0.78) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL6262602 | 0.82 | PTGS2 (0.71) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL8765035 | 0.82 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL6348464 | 0.81 | PTGS2 (0.76) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL8765046 | 0.81 | PTGS2 (0.67) | PTGS2PTGS1CA2CA1CA9 | |
| SCHEMBL8633382 | 0.81 | PTGS2 (0.65) | PTGS2PTGS1CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731794-B1 | 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS | SEARLE & CO (US) | 1997-08-06 | — | — | EP | disclosed |
| US-5639777-A | 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders | G.D. SEARLE & CO. (US) | 1997-06-17 | — | — | US | disclosed |
| EP-0731794-A1 | 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS | SEARLE & CO (US) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995015317-A1 | 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS | G.D. SEARLE & CO. (US) | 1995-06-08 | — | — | WO | disclosed |